Non-Pharmacological Interventions for Pain Management in Hemodialysis: A Narrative Review

Abstract

This narrative review aims to summarize non-pharmacological interventions for pain management in hemodialysis patients, assessing their potential benefits and limitations in enhancing patient well-being and quality of life. We reviewed the current literature on five primary non-pharmacological interventions: acupuncture, cognitive behavioral therapy, relaxation techniques, virtual reality, and alternative methods such as transcutaneous electrical nerve stimulation, music therapy, and aromatherapy. We analyzed the evidence regarding their effectiveness, feasibility, and optimal implementation strategies. The existing evidence supports the potential benefits of these interventions in managing pain and improving the well-being of hemodialysis patients. However, further high-quality research is needed to confirm their effectiveness, establish implementation best practices, and assess their long-term impact on patient outcomes. Non-pharmacological interventions hold promise for pain management in hemodialysis patients. Additional research is required to optimize these interventions and validate their effectiveness, contributing to comprehensive pain management strategies for this vulnerable patient population.

Palliative Care for Adult Patients Undergoing Hemodialysis in Asia: Challenges and Opportunities

“…An effective pain management strategy is crucial for enhancing patient compliance with the hemodialysis regimen and can substantially improve the overall treatment experience. Furthermore, optimal pain management is essential for promoting the physical, mental, and emotional well-being of patients [ 14 ].…”

Non-Pharmacological Pain Management in Labor: A Systematic Review

“…With the rise of digital health solutions, their role in NPPM deserves further exploration. There may be opportunities to leverage technology to enhance the effectiveness of NPPM, as in virtual reality and mobile apps, which may facilitate relaxation or deliver personalized pain strategies [144,145].…”

Clinical Perspectives of Gut Microbiota in Patients with Chronic Kidney Disease and End-Stage Kidney Disease: Where Do We Stand?

“…CKD and ESKD affect roughly 10 percent of the world’s population and impose a substantial financial burden on the healthcare system [ 19 ]. Owing to an insufficient understanding of both the origin and the bodily responses associated with CKD, there have not been any significant advances in decades, despite efforts to slow the progression of CKD [ 20 , 21 ].…”